scholarly journals Progress on Seasonal and Pandemic Influenza Vaccines

Vaccines ◽  
2021 ◽  
Vol 9 (10) ◽  
pp. 1068
Author(s):  
Claudia Maria Trombetta ◽  
Emanuele Montomoli

Influenza is a vaccine-preventable disease and vaccination is the most effective way of controlling seasonal influenza infections and preventing possible pandemic events [...]

Vaccine ◽  
2012 ◽  
Vol 30 (38) ◽  
pp. 5644-5650 ◽  
Author(s):  
Angela Domínguez ◽  
Jesús Castilla ◽  
Pere Godoy ◽  
Miguel Delgado-Rodríguez ◽  
Vicente Martín ◽  
...  

2015 ◽  
Vol 213 (3) ◽  
pp. 403-406 ◽  
Author(s):  
Wei Wang ◽  
Esmeralda Alvarado-Facundo ◽  
Qiong Chen ◽  
Christine M. Anderson ◽  
Dorothy Scott ◽  
...  

2011 ◽  
Vol 140 (7) ◽  
pp. 1309-1315 ◽  
Author(s):  
K. T. D. EAMES ◽  
E. BROOKS-POLLOCK ◽  
D. PAOLOTTI ◽  
M. PEROSA ◽  
C. GIOANNINI ◽  
...  

SUMMARYThe effectiveness of influenza vaccination programmes is seldom known during an epidemic. We developed an internet-based system to record influenza-like symptoms and response to infection in a participating cohort. Using self-reports of influenza-like symptoms and of influenza vaccine history and uptake, we estimated vaccine effectiveness (VE) without the need for individuals to seek healthcare. We found that vaccination with the 2010 seasonal influenza vaccine was significantly protective against influenza-like illness (ILI) during the 2010–2011 influenza season (VE 52%, 95% CI 27–68). VE for individuals who received both the 2010 seasonal and 2009 pandemic influenza vaccines was 59% (95% CI 27–77), slightly higher than VE for those vaccinated in 2010 alone (VE 46%, 95% CI 9–68). Vaccinated individuals with ILI reported taking less time off work than unvaccinated individuals with ILI (3·4 days vs. 5·3 days, P<0·001).


2010 ◽  
Vol 202 (11) ◽  
pp. 1634-1638 ◽  
Author(s):  
Glendie Marcelin ◽  
Hilliary M. Bland ◽  
Nicholas J. Negovetich ◽  
Matthew R. Sandbulte ◽  
Ali H. Ellebedy ◽  
...  

Vaccines ◽  
2021 ◽  
Vol 9 (7) ◽  
pp. 765
Author(s):  
Amel Ahmed Fayed ◽  
Abeer Salem Al Shahrani ◽  
Leenah Tawfiq Almanea ◽  
Nardeen Ibrahim Alsweed ◽  
Layla Mohammed Almarzoug ◽  
...  

This study aimed to assess the willingness to receive the coronavirus disease 2019 (COVID-19) and seasonal influenza vaccines and vaccine uptake during the early stage of the national vaccination campaign in Saudi Arabia. A cross-sectional online survey was conducted among adult Saudis between 20 January and 20 March 2021. The questionnaire addressed vaccine hesitancy, perceived risk, willingness, and vaccine uptake. Approximately 39% of the participants expressed vaccine hesitancy, and 29.8% and 24% felt highly vulnerable to contracting COVID-19 and seasonal influenza, respectively. The majority (59.5%) were willing to receive the COVID-19 vaccine, although only 31.7% were willing to receive the flu vaccine. Adjusted analysis showed that vaccine hesitancy (OR 0.34, 95% CI 0.27–0.43) and the perception of being at high risk (OR 2.78, 95% CI 1.68–4.60) independently affected the intention to be vaccinated. Vaccine hesitancy was similar among those who were willing to be vaccinated (29.8%) and those who had already been vaccinated (33.1%). The perceived risk was significantly higher among those who had been vaccinated (48.1%) than among those who were willing to be vaccinated but had not yet been vaccinated (29.1%). In conclusion, the acceptance of the COVID-19 vaccine in Saudi Arabia is high. Saudis who received the vaccine had a similar level of vaccine hesitancy and a higher level of perceived risk.


Sign in / Sign up

Export Citation Format

Share Document